Clinical trial reportClinical cancer research : an official journal of the American Association for Cancer ResearchPublished
First-in-Human Clinical Trial of a Small-Molecule EBNA1 Inhibitor, VK-2019, in Patients with Epstein-Barr-Positive Nasopharyngeal Cancer, with Pharmacokinetic and Pharmacodynamic Studies
Regional connection
Verified An author affiliation on the Europe PMC record names The Wistar Institute. Affiliation source
- Institution
- The Wistar Institute
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Clinical cancer research : an official journal of the American Association for Cancer Research
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Herpesvirus 4, Human; Epstein-Barr Virus Infections; Nasopharyngeal Neoplasms; DNA, Viral; Epstein-Barr Virus Nuclear Antigens; Adult; Aged; Middle Aged; Female; Male; Nasopharyngeal Carcinoma
- PubMed ID
- 39831818
- PubMed Central ID
- PMC11915201
- Open access
- Yes, accepted manuscript
- Added to directory
- Source checked